Compare Organo Corp. with Similar Stocks
Dashboard
1
Strong Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 17.33%
- Healthy long term growth as Net Sales has grown by an annual rate of 12.36% and Operating profit at 37.26%
- Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 96.69
2
Negative results in Jun 26
3
With ROCE of 26.70%, it has a attractive valuation with a 5.38 Enterprise value to Capital Employed
4
Underperformed the market in the last 1 year
Stock DNA
Industrial Manufacturing
JPY 709,767 Million (Mid Cap)
26.00
NA
0.00%
0.02
19.91%
4.96
Revenue and Profits:
Net Sales:
42,183 Million
(Quarterly Results - Jun 2026)
Net Profit:
3,436 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.52%
0%
-13.52%
6 Months
2.18%
0%
2.18%
1 Year
28.35%
0%
28.35%
2 Years
123.58%
0%
123.58%
3 Years
289.69%
0%
289.69%
4 Years
50.83%
0%
50.83%
5 Years
140.98%
0%
140.98%
Organo Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.36%
EBIT Growth (5y)
37.26%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0.41
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
1.11
Tax Ratio
25.86%
Dividend Payout Ratio
32.38%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.75%
ROE (avg)
14.66%
Valuation key factors
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
5.71
EV to EBIT
20.16
EV to EBITDA
19.13
EV to Capital Employed
5.38
EV to Sales
4.31
PEG Ratio
0.77
Dividend Yield
NA
ROCE (Latest)
26.70%
ROE (Latest)
21.62%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
42,183.00
38,110.00
10.69%
Operating Profit (PBDIT) excl Other Income
7,108.00
7,405.00
-4.01%
Interest
96.00
65.00
47.69%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3,436.00
3,642.00
-5.66%
Operating Profit Margin (Excl OI)
156.80%
182.50%
-2.57%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 10.69% vs 20.53% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is -5.66% vs 35.74% in Jun 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
177,654.00
163,269.00
8.81%
Operating Profit (PBDIT) excl Other Income
39,630.00
33,046.00
19.92%
Interest
298.00
246.00
21.14%
Exceptional Items
0.00
0.00
Consolidate Net Profit
28,401.00
24,186.00
17.43%
Operating Profit Margin (Excl OI)
211.90%
190.60%
2.13%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 8.81% vs 8.59% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 17.43% vs 39.53% in Mar 2025
About Organo Corp. 
Organo Corp.
Industrial Manufacturing
No Details Available.
Company Coordinates 
No Company Details Available






